Viper Partners, a healthcare-focused advisory firm, is pleased to announce that it served as the exclusive advisor to Vascular Specialists in its strategic partnership with CUC America, a leading healthcare services organization focused on supporting physician-led specialty platforms.
Vascular Specialists is a premier vascular care provider dedicated to delivering comprehensive diagnosis and treatment for patients with vascular disease. The practice has built a strong reputation for clinical excellence, advanced treatment capabilities, and patient-centered care across the markets it serves. Through its experienced team of physicians and clinical staff, the organization provides a full range of vascular services including minimally invasive procedures, diagnostic testing, and ongoing disease management.
The partnership with CUC America represents a significant milestone for Vascular Specialists as the practice continues to expand its clinical capabilities and geographic reach. Through this collaboration, Vascular Specialists will benefit from CUC America’s operational resources, infrastructure support, and strategic growth expertise, enabling the physicians to remain focused on delivering high-quality patient care while accelerating long-term expansion.
“Vascular Specialists has built an exceptional clinical platform with a strong reputation in vascular medicine,” said Samir Qureshi, President of Viper Partners. “This partnership with CUC America positions the practice for continued growth while preserving the physician-led culture and commitment to patient outcomes that has defined the organization.”
CUC America partners with leading physician groups across the United States, providing capital, operational expertise, and infrastructure designed to support the growth of specialty healthcare platforms while maintaining clinical autonomy.
The transaction reflects continued momentum in physician practice partnerships, particularly in specialty medical fields where scaled infrastructure and operational support can enhance both patient access and clinical outcomes.
